SMV + SOF With/Without RBV for IFN-II Patients With CHC

NCT02214420 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Simeprevir
DRUG: Sofosbuvir
DRUG: Ribavirin

Sponsor

SC Liver Research Consortium, LLC

Collaborators

[object Object]